Shares of several vaccine makers including Pfizer and Astrazeneca were down Friday morning following the nomination of Robert ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

Bavarian Nordic, a maker of the mpox vaccine, on Friday said the incoming Trump administration may present opportunities even ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

Timely vaccinations are essential for protecting children from various communicable diseases, offering up to 90% immunity and ...

“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week findings from the DOLCE study, sponsored by Fundación ...

A scaled-down campaign to administer a second dose of the polio vaccine began Saturday in parts of northern ... Business ...

After a median follow up of 24.1 months, all 16 patients who received TG4050 ... and machine learning (ML) expertise. This virus-based therapeutic vaccine encodes neoantigens (patient-specific ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...